Alembic share news, announcements and annual reports
NSE: ALEMBICLTDBSE: 506235RealtySmall Cap
Alembic Limited · Formerly Alembic Chemical Works Co. · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1934 on BSE, Sep 1999 on NSE
Last close ₹89.31up ₹1.72 (1.96%)BSE ₹89.45
Share price at the NSE close on 29 Oct 2026. Previous close ₹87.59.
29 Oct: open ₹87.00, high ₹89.49, low ₹86.86
52-week range of traded prices to 29 Oct 2026
₹70.46Low, 30 Mar 2026₹117.72High, 3 Sep 2026
- Next results date: the board meets on 6 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,293 Cr1,101st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 7.15
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.94
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.69%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,69,68150.2% delivered
Alembic orders, deals and press releases
28 filed, newest first.
Apr 2020
Nov 2018
Oct 2013
3 Oct · Business
Allotment Committee of the Board of Directors of the Company has allotted 13,35,15,914 Bonus Shares in the ratio of 1:1 (One Share for every one Share held) to the Shareholders of the Company.
Feb 2011
24 Feb · Business
Petition filed by the Company for approval of Scheme of Arrangement in nature of demerger and transfer of the Pharmaceutical Undertaking of Alembic Limited as a going concern to Alembic Pharma Limited, and consequential Re-organisation of its Share Capital, pursuant to Sections 391 to 394 read with Sections 78 and 100 to 104 and other relevant provisions of the Companies Act, 1956 has been sanctioned by the Hon'ble High Court of Gujarat vide Oral Order dated January 24, 2011 received by the Company on February 23, 2011.
Jan 2011
Oct 2010
Jul 2010
Jun 2010
May 2010
Jan 2010
25 Jan · Business
Press release dated January 25, 2010, titled "Alembic Ltd. Consolidated Results for quarter ended 31.12.2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
15 Oct · Business
Press release dated October 15, 2009, titled "Alembic Ltd. Consolidated Results for quarter ended September 30, 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
28 Jul · Business
Press release dated July 28, 2009, titled "Alembic Ltd. Consolidated Results for quarter ended June 30, 2009". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
8 May · Business
Press release dated May 08, 2009, titled "Consolidated Results for year 31.03.2009 Revenues up 11% at Rs 1116 crores". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
29 Jan · Business
Press release dated January 28, 2009, titled "Q3 FY09 Net Sales at Rs 286 crore up 8%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
20 Oct · Business
Press release dated October 20, 2008, titled "Revenues up 12% at Rs. 352 crore; Export sales up by 57%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
28 Jul · Business
Press release dated July 28, 2008, titled "Q1 results; Revenues up 33% at Rs 236 crore; Export sales up 279% at Rs 113 crore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
25 Apr · Business
Press release dated April 25, 2008, titled "Revenues up 42% at Rs 1027 crore; PAT up 59% at Rs 112 crore; Dividend 75%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2008
31 Mar · Business
Vide its letter dated March 31, 2008, that: "The Celebration Programme of Centenary Year of Alembic Limited scheduled to be organized from March 28, 2008 to March 31, 2008 has been successfully completed today. On this day, the Hon'ble Dr. APJ Abdul Kalam, former President of India and Hon'ble Mr. Narendra Modi, Chief Minister of Gujarat has released the Book(s) on Alembic's 100 year journey". Further, the Company has submitted to the Exchange a copy of the press release dated March 31, 2008, titled "Alembic eyeing for Rs 2000 crore revenues in four years". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Mar · Business
Press release dated March 27, 2008, titled "Alembic to celebrate 'Centenary Week' ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
24 Jan · Business
Press release dated January 24, 2008, titled "Q3 FY08 Sales at Rs.265 crore up 39% PAT at Rs 42 crore up 67%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Jan · Business
Press release dated January 3, 2008, titled "Alembic acquires API manufacturing Unit". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
17 Oct · Business
Press release dated October 17, 2007, titled "Revenues up 51% at Rs 315 crore; PBIDTA up 44% at 62 crore; PBT up 142% at Rs 46 crore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
19 Jul · Business
Press release dated July 18, 2007, titled "Revenues up 17% at Rs 178 crore; PBIDTA up 50% at 32 crore; PBT up 23% at Rs 17 crore". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
23 May · Business
Alembic Limited, the Pharmaceutical major announced on May 23, 2007 that it has entered into a licensing agreement for its Novel Drug Delivery Platform for Keppra (R) XR (Levetiracetam Extended Release Tablets with UCB. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 May · Business
Press release dated May 22, 2007, titled "Revenues up 8% at Rs.722 crore; Non recurring items hit PAT; PAT at Rs.71 crore, down 10%". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2007
12 Apr · Business
"The Company has completed the formalities in respect of acquisition of Non-Oncology Business of Dabur Pharma Ltd." Further the Company has submitted to the Exchange a copy of Press Release dated April 12, 2007, titled "Alembic enters Chronic Lifestyle Therapeutic Segments with 24 Brands." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2007
1 Feb · Business
Press release dated January 31, 2007, titled "Alembic acquires Non-Oncology Business of Dabur Pharma Ltd. Charts high growth trajectory with entry into life style segments". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2007
17 Jan · Business
Press release dated January 17, 2007, titled Alembic Limited Q3 Results". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.